Postoperative hypofractionated proton beam therapy to control recurrent paraganglioma at the jugular foramen: A case report

Paragangliomas (PGLs) are rare neuroendocrine tumors with malignant potential that may prove challenging to manage. Those arising at the jugular foramen are particularly problematic, especially if recurring after primary surgical treatment. Long-term follow-up is required, and effective treatment options for such recurrences are needed. The present study chronicles a recurring PGL of the jugular foramen that emerged after two surgeries. Alternative therapeutic strategies were accordingly pursued. This account of the related clinical course includes a discussion of the associated literature, focusing on the role of proton beam therapy (PBT) in PGL management and its benefits. The patient under treatment received hypofractionated PBT, utilizing intensity-modulated proton therapy/pencil-beam scanning techniques. The prescribed dose was 40 Gy in 15 fractions [equivalent dose in 2-gy fractions (EQD2), 42.09 Gy, assuming α/β=10) delivered to the gross tumor volume (GTV). Simultaneous integrated boosts to two inner subvolumes [GTV reduced by 2-mm margin, 50 Gy/15 fractions (EQD2, 55.49 Gy); and GTV reduced by 3-mm margin, 60 Gy/15 fractions (EQD2, 70.00 Gy)] took place as well. This process ensured precise radiation dosing, while adhering to strict dose constraints for adjacent critical structures. Hence, a quicker therapeutic response (aligned with that of stereotactic radiotherapy principles) was tenable, aiming for both tumor control and clinical improvement. Long-term follow-up is imperative to assess outcome durability. The aforementioned events illustrate the potential utility of advanced PBT techniques (namely pencil-beam scanning, hypofractionated regimens) in managing PGL recurrences of this type, especially if surgical options are limited or carry substantial risks. PBT offers a precise therapeutic alternative, with tumor control capabilities that promise to preserve critical tissues near key locations at the base of the skull.

Authors

Institutions

Publication Details

Journal
Experimental and Therapeutic Medicine
Published
2026-01-16
DOI
https://doi.org/10.3892/etm.2026.13065
Primary Topic
Adrenal and Paraganglionic Tumors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Postoperative hypofractionated proton beam therapy to control recurrent paraganglioma at the jugular foramen: A case report

Jian Kong, Masashi Mizumoto, S Y Zhang, Hideyuki Sakurai et al.
Experimental and Therapeutic Medicine
Adrenal and Paraganglionic Tumors
article

Postoperative hypofractionated proton beam therapy to control recurrent paraganglioma at the jugular foramen: A case report

Jian Kong, Masashi Mizumoto, S Y Zhang, Hideyuki Sakurai, Dongxue Zhou, Jun Zhao, Wei Wang, Shosei Shimizu, Jie Wang, Zishen Wang, Lu Yang, Yingxia Yuan, Jiwei Bai, Yue Zou
article en

Abstract

Paragangliomas (PGLs) are rare neuroendocrine tumors with malignant potential that may prove challenging to manage. Those arising at the jugular foramen are particularly problematic, especially if recurring after primary surgical treatment. Long-term follow-up is required, and effective treatment options for such recurrences are needed. The present study chronicles a recurring PGL of the jugular foramen that emerged after two surgeries. Alternative therapeutic strategies were accordingly pursued. This account of the related clinical course includes a discussion of the associated literature, focusing on the role of proton beam therapy (PBT) in PGL management and its benefits. The patient under treatment received hypofractionated PBT, utilizing intensity-modulated proton therapy/pencil-beam scanning techniques. The prescribed dose was 40 Gy in 15 fractions [equivalent dose in 2-gy fractions (EQD2), 42.09 Gy, assuming α/β=10) delivered to the gross tumor volume (GTV). Simultaneous integrated boosts to two inner subvolumes [GTV reduced by 2-mm margin, 50 Gy/15 fractions (EQD2, 55.49 Gy); and GTV reduced by 3-mm margin, 60 Gy/15 fractions (EQD2, 70.00 Gy)] took place as well. This process ensured precise radiation dosing, while adhering to strict dose constraints for adjacent critical structures. Hence, a quicker therapeutic response (aligned with that of stereotactic radiotherapy principles) was tenable, aiming for both tumor control and clinical improvement. Long-term follow-up is imperative to assess outcome durability. The aforementioned events illustrate the potential utility of advanced PBT techniques (namely pencil-beam scanning, hypofractionated regimens) in managing PGL recurrences of this type, especially if surgical options are limited or carry substantial risks. PBT offers a precise therapeutic alternative, with tumor control capabilities that promise to preserve critical tissues near key locations at the base of the skull.

Experimental and Therapeutic MedicineVol. 31(3)
University of Tsukuba (JP), Hebei North University (CN), Beijing Tian Tan Hospital (CN), University of Tsukuba Hospital (JP)
Good health and well-being
Openalex Percentile: Top 86%
Adrenal and Paraganglionic Tumors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.